Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Acquisitions (2014 - 2015)

Updated

Grace Therapeutics (GRCE) posted Acquisitions of $2.61 million for fiscal Q3 2016 (quarter ended Nov 30, 2015), compared with -$66,174 a year earlier.

Analysis

Grace Therapeutics (GRCE) Acquisitions (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -17.15 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.59 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 19.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2015 2.61 Mn
Nov 30, 2014 -66,174.00
API Access

Grace Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=GRCE&period=max&api_key=YOUR_API_KEY